|Day Low/High||34.96 / 35.74|
|52 Wk Low/High||3.80 / 35.79|
The good vibes that carried Wall Street to new records last week lingered on into Monday's session.
The Dow Jones Industrial Average led Wall Street's gains on Monday on leftover goodwill from last week's Trump-inspired rally.
The New Facility Will Triple the Company's Capacity of Its Low Global Warming Potential, HFO-1234yf-Based Refrigerant Products
Jim Cramer is bullish on Box and Six Flags; bearish on Chemours and Zoe's Kitchen.
Jim Cramer says: Evaluate the individual companies in the Dow based on fundamentals, not some 'Trumpian alchemy.'
Cramer is taking Magellan Midstream Partners over EQT Midstream and is waiting for Ionis Pharmaceuticals to go lower.
Buccini/Pollin Group to Purchase the Building, Renovate, and Lease Office Space Back to Chemours
Going into earnings what the market needs now is more negativity, Cramer says.
Jim Cramer says he's still 'a believer' in KKR and Opko.
Stocks kept rallying right through and after this rate hike, says Jim Cramer.
Jim Cramer urges caution with phamaceutical companies Supernus and Ariad
Jim Cramer explains the rotation, looks ahead to next week.
These stocks have short-term gain catalysts and longer-term growth potential.
The tech-heavy Nasdaq struggled as a weak Intel weighed on the index, which closed flat.
The Amendment Will Dramatically Reduce the Global Use of Hydrofluorocarbons in Effort to Address Climate Change Potential and Could Help Eliminate Up to 0.5C Temperature Rise
Chemours highlights the periodic table as the cornerstone of product innovation and learning
Chemours to Showcase its Latest Innovation in Refrigerant Technology, the Opteon™ XL Series, at the 2016 Chillventa International Exhibition
The Low Global Warming Potential Refrigerant Helped Ahold Reduce CO2 Emissions by Over 57,000 Tons per Year at Zero Additional Abatement Cost
The Company's Latest Estimate Represents an Eight Percent Improvement vs. Its 2015 Evaluation and Is Aligned with Today's Call from Global Leaders to Amend the Montreal Protocol
Chemours is up over 153% year-to-date and more than 50% since a short-seller targeted the chemical maker.
When KKR and Apollo sell a stock it should be a huge red flag to investors to consider following suit.